Takara Bio Inc.
4974.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥112,227 | ¥96,814 | ¥99,704 | ¥126,436 |
| - Cash | ¥18,994 | ¥22,006 | ¥29,549 | ¥28,705 |
| + Debt | ¥10,000 | ¥9,992 | ¥1,101 | ¥1,287 |
| Enterprise Value | ¥103,233 | ¥84,800 | ¥71,256 | ¥99,018 |
| Revenue | ¥9,528 | ¥9,266 | ¥15,757 | ¥9,524 |
| % Growth | 2.8% | -41.2% | 65.4% | – |
| Gross Profit | ¥5,560 | ¥5,004 | ¥9,697 | ¥3,925 |
| % Margin | 58.4% | 54% | 61.5% | 41.2% |
| EBITDA | -¥3,078 | -¥305 | ¥4,492 | -¥570 |
| % Margin | -32.3% | -3.3% | 28.5% | -6% |
| Net Income | -¥5,401 | -¥1,510 | ¥2,420 | -¥1,891 |
| % Margin | -56.7% | -16.3% | 15.4% | -19.9% |
| EPS Diluted | -44.84 | -12.55 | 20.09 | -15.7 |
| % Growth | -257.3% | -162.5% | 228% | – |
| Operating Cash Flow | ¥1,132 | ¥1,912 | ¥961 | -¥1,216 |
| Capital Expenditures | -¥11,779 | -¥377 | -¥266 | -¥8,488 |
| Free Cash Flow | -¥10,647 | ¥1,535 | ¥695 | -¥9,704 |